Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outset Medical, Inc. - Common Stock (NQ:OM)

13.02 -0.10 (-0.76%)
Streaming Delayed Price Updated: 3:03 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Outset Medical, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Earnings This Week: Big Tech, UK Banks And Oil Giants
The US, UK, and European calendars are jam-packed this week. 
Via Talk Markets
The Law Offices of Frank R. Cruz Continues Its Investigation of Outset Medical, Inc. (OM) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Why Shares of Outset Medical Are Down Monday
The company's issues with the FDA are dragging on. 
Via The Motley Fool
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Outset Medical, Inc. Investors to Inquire About Securities Class Action Investigation – OM
From Rosen Law Firm
Via Business Wire
Outset Medical to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023
From Outset Medical, Inc.
Via Business Wire
Shareholders in These 2 Stocks Got Nasty Surprises Monday
These companies are starting off the week with big declines. 
Via The Motley Fool
Outset Medical to Present at Goldman Sachs 44th Annual Global Healthcare Conference
From Outset Medical, Inc.
Via Business Wire
Outset Medical's Return On Capital Employed Overview
 
Via Benzinga
Outset Medical's Return On Capital Employed Insights
 
Via Benzinga
The Ultimate Growth Stocks to Buy With $1,400 Right Now
There are still plenty of top growth companies at great prices for investors to buy now. 
Via The Motley Fool
Outset Medical Reports First Quarter 2023 Financial Results
From Outset Medical, Inc.
Via Business Wire
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
Each of these stocks could at least quadruple an initial investment over the next 10 years. 
Via The Motley Fool
Outset Medical to Present at Upcoming Investor Conferences
From Outset Medical, Inc.
Via Business Wire
This Could Be the Best Growth Stock Under $20 on the Market Right Now
Home is where the big money is for this up-and-coming healthcare company. 
Via The Motley Fool
Outset Medical to Present Research Highlighting Home Hemodialysis Success for Underserved Populations at National Kidney Foundation Spring Clinical Meetings
From Outset Medical, Inc.
Via Business Wire
Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023
From Outset Medical, Inc.
Via Business Wire
There's More to the Mint Mobile Deal Than Ryan Reynolds
Are General Motors and Outset Medical on your radar? 
Via The Motley Fool
Shopify Had Mixed News for Investors
And that's just the tip of the iceberg as these investors look at the latest quarterly reports from lots of companies. 
Via The Motley Fool
Outset Medical to Present at 43rd Annual Cowen Health Care Conference
From Outset Medical, Inc.
Via Business Wire
Better Medtech Stock to Buy: InMode or Outset Medical?
Here are the "ins and outs" for these two stocks. 
Via The Motley Fool
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users. 
Via Benzinga
Why Shares of Outset Medical Are Down Tuesday
The medical technology company, which makes a portable dialysis machine, delivered its fourth-quarter and full-year report on Monday. 
Via The Motley Fool
These 2 Nasdaq Stocks Got No Valentine's Day Love
Quarterly financial performance left something to be desired from both of these companies. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! 
Via InvestorPlace
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,... 
Via Benzinga
Outset Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Outset Medical, Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.